Cargando…
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
SIMPLE SUMMARY: The telomeric protein TRF2 (Telomeric repeat-binding factor 2) is upregulated in human cancers and associated with poor prognosis. TRF2 oncogenic properties rely on its intrinsic telomere protective role, but also on cell extrinsic effects through immunosuppressive and angiogenic act...
Autores principales: | El Maï, Mounir, Janho dit Hreich, Serena, Gaggioli, Cedric, Roisin, Armelle, Wagner, Nicole, Ye, Jing, Jalinot, Pierre, Cherfils-Vicini, Julien, Gilson, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232760/ https://www.ncbi.nlm.nih.gov/pubmed/34203903 http://dx.doi.org/10.3390/cancers13122998 |
Ejemplares similares
-
Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
por: Cherfils‐Vicini, Julien, et al.
Publicado: (2019) -
TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization
por: Galati, Alessandra, et al.
Publicado: (2015) -
TRF2 acts as a transcriptional regulator in tumor angiogenesis
por: Maï, Mounir El, et al.
Publicado: (2015) -
The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA
por: Poulet, Anaïs, et al.
Publicado: (2012) -
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
por: Opresko, Patricia L., et al.
Publicado: (2005)